EUA
DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit
FDA Emergency Use Authorization · SolGent Co., Ltd · Dec 28, 2020
Key facts
| Product | DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit |
|---|---|
| Company | SolGent Co., Ltd |
| Product type | Real-time RT-PCR, Multiple Targets |
| Date | Dec 28, 2020 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: